Complimentary shipping over $150 · Join Aurevia One for member pricing · NuraProof early access is open
Investors

Building the intelligence layer for modern wellness.

AUREVIA operates a premium commerce and member platform, NuraProof supplement intelligence, and Aurevia Evidence Sciences — the internal research and scientific-affairs function that keeps them honest.

Status

Company status.

AUREVIA does not represent itself as venture-backed or institutionally backed unless verified investment documentation is on file.

Company status
Configured by administrator
Funding round status
Not raising
Default state. Only changes with verified documentation.
Amount raised
Not yet publicly reported
Valuation
Not yet publicly reported
The problem

Consumer supplement information is fragmented, opaque and duplicative.

Shoppers rarely see product identity, ingredient forms, quantities, evidence or batch testing in one place — and almost never in relation to what they already take.

The platform

Three functions. One consumer relationship.

Business unit

AUREVIA

Premium commerce and member services.

Business unit

NuraProof

Supplement intelligence, organisation and personal tracking.

Business unit

AES

Evidence governance, research operations and scientific documentation.

Revenue architecture

Configurable revenue categories.

No revenue figures are displayed on this page. Revenue detail is disclosed only inside the verified investor data room.

Product marginReserved
MembershipReserved
Premium software subscriptionReserved
Marketplace revenueReserved
Device revenueReserved
Exclusive distributionReserved
Practitioner toolsReserved
Verification servicesReserved
Enterprise wellnessReserved
Research collaborationReserved
Data moat

Potential future value.

These datasets are described as future potential, not present scale. Nothing here is claimed to exist at scale unless verified.

Product graphIngredient graphEvidence graphBatch-quality graphConsent-based response dataAdherence patternsProduct-comparison behaviour
DisclosureNothing on this page constitutes an offer to sell or a solicitation of an offer to buy any security. Access to non-public information requires investor registration, identity verification and NDA acceptance in the data room.